Natera CFO Michael Burkes sells $4.28m in inventory

Michael Burkes, Chief Monetary Officer of Natera, Inc. (NASDAQ:NTRA), lately executed a sequence of inventory transactions as detailed in a Type 4 submitting with the Securities and Alternate Fee. On January 22, Burkes bought a complete of 25,931 shares of Natera’s frequent inventory, producing roughly $4.28 million. The shares had been bought at costs starting from $164.95 to $171.95 per share. The transaction comes as Natera, now valued at $22.7 billion, trades close to its 52-week excessive after a powerful 158% return over the previous yr. InvestingPro evaluation signifies the inventory is presently overvalued primarily based on its Honest Worth calculations.

In earlier transactions, Burkes acquired 2,667 shares of Natera frequent inventory on January 20 and 21 via the vesting of restricted inventory models, which had been recorded without charge. Following these transactions, Burkes holds 109,665 shares of Natera inventory immediately. In accordance with InvestingPro knowledge, the corporate maintains a GOOD general monetary well being rating, with liquid belongings exceeding short-term obligations. Uncover 10+ further unique ProTips and complete evaluation within the Professional Analysis Report.

In different latest information, Natera Inc . has expanded its patent infringement litigation towards NeoGenomics (NASDAQ:NEO), Inc., including an extra patent to the continued lawsuit over the RaDaR assay. The corporate additionally reported a big 64% enhance in Q3 income year-over-year, hitting a report $439.8 million. Analyst companies TD Cowen, Baird, and Jefferies have expressed confidence in Natera’s future efficiency, sustaining favorable rankings and elevating their value targets.

In response to those developments, Natera has revised its full-year income steering to between $1.61 billion and $1.64 billion. The corporate has additionally amended an settlement with its Government Chairman, Dr. Rabinowitz, outlining the phrases of his continued function.

Nevertheless, Natera confronted a setback in a false promoting lawsuit towards Guardant Well being (NASDAQ:GH). Regardless of this, the corporate stays dedicated to its disagreement with the choice. These are a few of the latest developments that supply insights into Natera’s present standing and progress.

This text was generated with the help of AI and reviewed by an editor. For extra info see our T&C.